Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02659059
Brief Title: Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (CheckMate 568)

First Submitted : January 15, 2016
First Submitted that Met QC Criteria : January 15, 2016
First Posted : January 20, 2016 (Estimate)

Certification/Extension First Submitted : June 21, 2019
Certification/Extension First Submitted that Met QC Criteria : July 2, 2019
Certification/Extension First Posted : July 9, 2019

Last Update Submitted that Met QC Criteria : August 13, 2020
Last Update Posted : August 20, 2020